The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S. Søgaard, Martin Tolstrup|PLoS Pathogens|2015Cited by 522
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine K. Vibholm, Ole S. Søgaard, Jørgen Agnholt et al.|Clinical Infectious Diseases|2017Cited by 146
Construction of a Gammaretrovirus with a Novel Tropism and Wild-Type Replication Kinetics Capable of Using Human APJ as Entry ReceptorShervin Bahrami, Finn Skou Pedersen, Kristina Pagh Friis et al.|Journal of Virology|2012Cited by 3
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patientsChristian Gytz Ammitzbøll, Anne Troldborg, Marianne Kragh Thomsen et al.|Clinical and Experimental Rheumatology|2023Cited by 3